ENTITY

InflaRx NV (IFRX US)

3
Analysis
Health CareUnited States
InflaRx N.V. operates as a clinical-stage biopharmaceutical company. The Company discovers and develops monoclonal antibodies drugs for the treatment of inflammatory diseases. InflaRx serves patients worldwide.
more
Company Event20 Mar 2026 12:00 • Upcoming
Add To Calendar
Company Event12 Nov 2025 03:30 • Latest
Company Event11 Nov 2025 05:00 • Upcoming
Add To Calendar
Company Event07 Aug 2025 19:00 • Upcoming
Add To Calendar
x